Otiprio: payments to doctors
Payments that named Otiprio as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $113K
- Providers
- 2,014
- Transactions
- 4,070
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,014 providers the average total is $56, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Alk-abello, Inc | $107,361 | 94.7% |
| Otonomy, Inc. | $3,532 | 3.1% |
| Glenmark Therapeutics Inc. | $2,487 | 2.2% |